Publication | Open Access
Sorafenib Ameliorates Renal Fibrosis through Inhibition of TGF-β-Induced Epithelial-Mesenchymal Transition
29
Citations
19
References
2015
Year
Our results suggest that sorafenib may useful for the treatment of renal fibrosis through the suppression of TGF-β/Smad3-induced EMT signaling.
| Year | Citations | |
|---|---|---|
Page 1
Page 1